Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 6.22988848 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 6.22988848 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.23040398 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.23040398 |
5 | modulation by symbiont of host immune response (GO:0052553) | 4.23040398 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.23040398 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.23040398 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.23040398 |
9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.18653913 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09899214 |
11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.05328879 |
12 | negative regulation of cell killing (GO:0031342) | 3.95964018 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95964018 |
14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.90600639 |
15 | macrophage activation involved in immune response (GO:0002281) | 3.74927085 |
16 | protein retention in ER lumen (GO:0006621) | 3.68719741 |
17 | detection of other organism (GO:0098543) | 3.57167751 |
18 | response to host immune response (GO:0052572) | 3.48700814 |
19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48700814 |
20 | COPII vesicle coating (GO:0048208) | 3.47896532 |
21 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.47757700 |
22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.47754740 |
23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44912668 |
24 | neutrophil activation (GO:0042119) | 3.41593235 |
25 | neutrophil activation involved in immune response (GO:0002283) | 3.40192276 |
26 | detection of bacterium (GO:0016045) | 3.38725689 |
27 | vesicle coating (GO:0006901) | 3.37932964 |
28 | synaptic vesicle maturation (GO:0016188) | 3.30471958 |
29 | response to host (GO:0075136) | 3.24223356 |
30 | response to host defenses (GO:0052200) | 3.24223356 |
31 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.24223356 |
32 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.23230008 |
33 | positive regulation of nuclease activity (GO:0032075) | 3.23039152 |
34 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.21077232 |
35 | NADH metabolic process (GO:0006734) | 3.16485597 |
36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15545733 |
37 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.11339504 |
38 | detection of external biotic stimulus (GO:0098581) | 3.10791314 |
39 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.09258828 |
40 | detection of molecule of bacterial origin (GO:0032490) | 3.08558390 |
41 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.08532179 |
42 | cerebellar Purkinje cell layer development (GO:0021680) | 3.05337325 |
43 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.04069640 |
44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03846779 |
45 | desmosome organization (GO:0002934) | 3.02227642 |
46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.98626413 |
47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.96689016 |
48 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.93519185 |
49 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.93463481 |
50 | establishment of skin barrier (GO:0061436) | 2.88863609 |
51 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.88554132 |
52 | granulocyte activation (GO:0036230) | 2.88362357 |
53 | macrophage activation (GO:0042116) | 2.88218146 |
54 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87152935 |
55 | ER-nucleus signaling pathway (GO:0006984) | 2.86950686 |
56 | hepatocyte apoptotic process (GO:0097284) | 2.86402766 |
57 | microglial cell activation (GO:0001774) | 2.85614532 |
58 | interferon-gamma secretion (GO:0072643) | 2.85417425 |
59 | valine metabolic process (GO:0006573) | 2.84939279 |
60 | cellular response to unfolded protein (GO:0034620) | 2.84915782 |
61 | response to pheromone (GO:0019236) | 2.83766203 |
62 | activation of protein kinase A activity (GO:0034199) | 2.83593034 |
63 | regulation of nuclease activity (GO:0032069) | 2.83312801 |
64 | tricarboxylic acid metabolic process (GO:0072350) | 2.82658186 |
65 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.80289077 |
66 | oxaloacetate metabolic process (GO:0006107) | 2.79935089 |
67 | cell communication by electrical coupling (GO:0010644) | 2.79563574 |
68 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.79225170 |
69 | succinate metabolic process (GO:0006105) | 2.78920512 |
70 | cell communication involved in cardiac conduction (GO:0086065) | 2.78843515 |
71 | neutrophil mediated immunity (GO:0002446) | 2.78202775 |
72 | protein targeting to Golgi (GO:0000042) | 2.77680087 |
73 | toxin metabolic process (GO:0009404) | 2.76535424 |
74 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75571733 |
75 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.75500303 |
76 | response to interleukin-15 (GO:0070672) | 2.74647749 |
77 | cellular response to topologically incorrect protein (GO:0035967) | 2.73697930 |
78 | leukocyte aggregation (GO:0070486) | 2.71853378 |
79 | 2-oxoglutarate metabolic process (GO:0006103) | 2.69360616 |
80 | tricarboxylic acid cycle (GO:0006099) | 2.69204693 |
81 | regulation of water loss via skin (GO:0033561) | 2.69040828 |
82 | regulation of synaptic vesicle transport (GO:1902803) | 2.67278004 |
83 | cellular response to interleukin-15 (GO:0071350) | 2.65701841 |
84 | positive regulation of vesicle fusion (GO:0031340) | 2.65248686 |
85 | insulin secretion (GO:0030073) | 2.64656069 |
86 | growth hormone secretion (GO:0030252) | 2.62308096 |
87 | synaptic vesicle exocytosis (GO:0016079) | 2.62103814 |
88 | macroautophagy (GO:0016236) | 2.61962270 |
89 | negative regulation of myotube differentiation (GO:0010832) | 2.59975539 |
90 | ER overload response (GO:0006983) | 2.57802405 |
91 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.57729443 |
92 | detection of biotic stimulus (GO:0009595) | 2.56954030 |
93 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.55489683 |
94 | exocrine pancreas development (GO:0031017) | 2.55464780 |
95 | neurotransmitter secretion (GO:0007269) | 2.55333932 |
96 | sodium ion export (GO:0071436) | 2.54467272 |
97 | sequestering of metal ion (GO:0051238) | 2.53875236 |
98 | sulfur amino acid catabolic process (GO:0000098) | 2.52793377 |
99 | negative regulation of B cell mediated immunity (GO:0002713) | 2.51836736 |
100 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.51836736 |
101 | response to endoplasmic reticulum stress (GO:0034976) | 2.50707000 |
102 | protein maturation by protein folding (GO:0022417) | 2.50345172 |
103 | endocrine pancreas development (GO:0031018) | 2.50197321 |
104 | lysine catabolic process (GO:0006554) | 2.49572443 |
105 | lysine metabolic process (GO:0006553) | 2.49572443 |
106 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.49022944 |
107 | glutamate secretion (GO:0014047) | 2.48736001 |
108 | regulation of female receptivity (GO:0045924) | 2.47501964 |
109 | alpha-linolenic acid metabolic process (GO:0036109) | 2.46093909 |
110 | regulation of ARF protein signal transduction (GO:0032012) | 2.45868684 |
111 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.45656224 |
112 | L-phenylalanine catabolic process (GO:0006559) | 2.45656224 |
113 | peptide hormone processing (GO:0016486) | 2.44018572 |
114 | potassium ion homeostasis (GO:0055075) | 2.42709077 |
115 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.42479558 |
116 | cellular potassium ion homeostasis (GO:0030007) | 2.42265146 |
117 | myeloid leukocyte mediated immunity (GO:0002444) | 2.42032390 |
118 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.41878126 |
119 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.41480310 |
120 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.41408722 |
121 | locomotory exploration behavior (GO:0035641) | 2.40909921 |
122 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.40703583 |
123 | regulation of beta-amyloid formation (GO:1902003) | 2.40244716 |
124 | establishment of protein localization to Golgi (GO:0072600) | 2.39250648 |
125 | response to peptidoglycan (GO:0032494) | 2.38572047 |
126 | regulation of cholesterol homeostasis (GO:2000188) | 2.38129595 |
127 | regulation of synapse structural plasticity (GO:0051823) | 2.38010117 |
128 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.37935359 |
129 | detection of calcium ion (GO:0005513) | 2.37435558 |
130 | beta-amyloid metabolic process (GO:0050435) | 2.37213975 |
131 | positive regulation of insulin secretion (GO:0032024) | 2.37076799 |
132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36854174 |
133 | cysteine metabolic process (GO:0006534) | 2.36573174 |
134 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.34854244 |
135 | cellular response to glucagon stimulus (GO:0071377) | 2.34145337 |
136 | cellular extravasation (GO:0045123) | 2.33262059 |
137 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.32323675 |
138 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31687155 |
139 | negative regulation of microtubule polymerization (GO:0031115) | 2.31474884 |
140 | L-phenylalanine metabolic process (GO:0006558) | 2.31308056 |
141 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.31308056 |
142 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.31149698 |
143 | intestinal epithelial cell development (GO:0060576) | 2.30030391 |
144 | layer formation in cerebral cortex (GO:0021819) | 2.28425460 |
145 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.28297563 |
146 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.26915393 |
147 | vocalization behavior (GO:0071625) | 2.24978012 |
148 | superoxide anion generation (GO:0042554) | 2.24968108 |
149 | 4-hydroxyproline metabolic process (GO:0019471) | 2.24870654 |
150 | positive regulation of regulated secretory pathway (GO:1903307) | 2.24840586 |
151 | regulation of insulin secretion (GO:0050796) | 2.24798814 |
152 | regulation of regulated secretory pathway (GO:1903305) | 2.24687541 |
153 | transcytosis (GO:0045056) | 2.24290811 |
154 | myeloid cell activation involved in immune response (GO:0002275) | 2.24245459 |
155 | peptide secretion (GO:0002790) | 2.22876080 |
156 | actin filament polymerization (GO:0030041) | 2.22223474 |
157 | response to unfolded protein (GO:0006986) | 2.22200772 |
158 | positive regulation of histone deacetylation (GO:0031065) | 2.22150627 |
159 | fatty acid beta-oxidation (GO:0006635) | 2.21389221 |
160 | protein localization to Golgi apparatus (GO:0034067) | 2.21094850 |
161 | respiratory burst (GO:0045730) | 2.21021012 |
162 | regulation of mast cell degranulation (GO:0043304) | 2.19931493 |
163 | fatty acid catabolic process (GO:0009062) | 2.19712626 |
164 | intestinal cholesterol absorption (GO:0030299) | 2.19710729 |
165 | Golgi organization (GO:0007030) | 2.18583959 |
166 | relaxation of cardiac muscle (GO:0055119) | 2.18294422 |
167 | peptidyl-asparagine modification (GO:0018196) | 2.18224571 |
168 | response to topologically incorrect protein (GO:0035966) | 2.18213959 |
169 | membrane repolarization during action potential (GO:0086011) | 2.17232161 |
170 | peptide hormone secretion (GO:0030072) | 2.17054711 |
171 | branched-chain amino acid metabolic process (GO:0009081) | 2.16997997 |
172 | mating behavior (GO:0007617) | 2.16965672 |
173 | positive regulation of exocytosis (GO:0045921) | 2.16822382 |
174 | regulation of leukocyte degranulation (GO:0043300) | 2.15058079 |
175 | regulation of cellular amide metabolic process (GO:0034248) | 2.14842115 |
176 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.14340843 |
177 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.13205184 |
178 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.12079435 |
179 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.11920594 |
180 | regulation of autophagic vacuole assembly (GO:2000785) | 2.10399013 |
181 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.09118042 |
182 | germinal center formation (GO:0002467) | 2.08878455 |
183 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.08393550 |
184 | negative regulation of interleukin-6 production (GO:0032715) | 2.07491709 |
185 | positive regulation of Rap GTPase activity (GO:0032854) | 2.07297045 |
186 | negative regulation of smooth muscle contraction (GO:0045986) | 2.05734467 |
187 | relaxation of smooth muscle (GO:0044557) | 2.05369058 |
188 | response to type I interferon (GO:0034340) | 2.04931102 |
189 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.04267291 |
190 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.04267291 |
191 | regulation of mast cell activation (GO:0033003) | 2.04123724 |
192 | activated T cell proliferation (GO:0050798) | 2.03457808 |
193 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.03300102 |
194 | dendritic cell migration (GO:0036336) | 2.03279321 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.23278997 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97616357 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73868973 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62170905 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.54182206 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36043097 |
7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.24252454 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23326542 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17276679 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12665211 |
11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11172366 |
12 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09433471 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05921800 |
14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.97617818 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91677226 |
16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85884976 |
17 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.82476165 |
18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78414681 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77115949 |
20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75446602 |
21 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.74888225 |
22 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73950052 |
23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.72085368 |
24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.68234255 |
25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67126488 |
26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.65898588 |
27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65739987 |
28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65628656 |
29 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.65298187 |
30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64868605 |
31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61956297 |
32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60427884 |
33 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.58301889 |
34 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57458713 |
35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55679692 |
36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54756502 |
37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48952338 |
38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47842416 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47687532 |
40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40239522 |
41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39850942 |
42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39744883 |
43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38886009 |
44 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.38558537 |
45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37206616 |
46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36832325 |
47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36812571 |
48 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36010098 |
49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35251125 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34638859 |
51 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34462374 |
52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33629467 |
53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32934887 |
54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32062980 |
55 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31264211 |
56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30730259 |
57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30151629 |
58 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.29968639 |
59 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29479946 |
60 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28307014 |
61 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.28084981 |
62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27788459 |
63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27068640 |
64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25307509 |
65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25177408 |
66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25030889 |
67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24485616 |
68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23070753 |
69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22365753 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20280963 |
71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20195432 |
72 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.19828861 |
73 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18906678 |
74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15560868 |
75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15014173 |
76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13337684 |
77 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12418450 |
78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11092114 |
79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11061331 |
80 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10837566 |
81 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09947719 |
82 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09820894 |
83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09692905 |
84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08684498 |
85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08310633 |
86 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08105838 |
87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07859621 |
88 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07604916 |
89 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07503543 |
90 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07503543 |
91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07461478 |
92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06693108 |
93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05812924 |
94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05725436 |
95 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05473082 |
96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05253610 |
97 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05070375 |
98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04949996 |
99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03718852 |
100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03599807 |
101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02407662 |
102 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02029131 |
103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01494593 |
104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00935917 |
105 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99506159 |
106 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99465387 |
107 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.99219624 |
108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99173224 |
109 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99114363 |
110 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98946785 |
111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98691847 |
112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98210375 |
113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98210375 |
114 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.97436373 |
115 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97301455 |
116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96119621 |
117 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.96099939 |
118 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95526840 |
119 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95151693 |
120 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94962637 |
121 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94847114 |
122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94688181 |
123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94648608 |
124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94138753 |
125 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93487801 |
126 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92964059 |
127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92521003 |
128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92521003 |
129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92256898 |
130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91896644 |
131 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91683106 |
132 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91480282 |
133 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90716808 |
134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90588638 |
135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90000394 |
136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89838546 |
137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89728532 |
138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89325026 |
139 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88900150 |
140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88841381 |
141 | AR_19668381_ChIP-Seq_PC3_Human | 0.88779404 |
142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87543418 |
143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87307743 |
144 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87225719 |
145 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86567044 |
146 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85411533 |
147 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85220991 |
148 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85055206 |
149 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84712035 |
150 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84419631 |
151 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84269203 |
152 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84120077 |
153 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83967919 |
154 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83496000 |
155 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83077008 |
156 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82989182 |
157 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.82781749 |
158 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.82443694 |
159 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81861472 |
160 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.81227369 |
161 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81069086 |
162 | P68_20966046_ChIP-Seq_HELA_Human | 0.80463186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 3.91294858 |
2 | MP0003724_increased_susceptibility_to | 3.73821442 |
3 | MP0009780_abnormal_chondrocyte_physiolo | 3.57263763 |
4 | MP0004381_abnormal_hair_follicle | 3.56494484 |
5 | MP0002909_abnormal_adrenal_gland | 3.26796779 |
6 | MP0002139_abnormal_hepatobiliary_system | 3.14649194 |
7 | MP0008260_abnormal_autophagy | 2.90481736 |
8 | MP0000013_abnormal_adipose_tissue | 2.78744710 |
9 | MP0010386_abnormal_urinary_bladder | 2.71881997 |
10 | MP0010234_abnormal_vibrissa_follicle | 2.64219498 |
11 | MP0005365_abnormal_bile_salt | 2.59393051 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.54042624 |
13 | MP0004043_abnormal_pH_regulation | 2.50932879 |
14 | MP0005377_hearing/vestibular/ear_phenot | 2.49919622 |
15 | MP0003878_abnormal_ear_physiology | 2.49919622 |
16 | MP0001666_abnormal_nutrient_absorption | 2.23074572 |
17 | MP0002653_abnormal_ependyma_morphology | 2.22690354 |
18 | MP0003787_abnormal_imprinting | 2.22624008 |
19 | MP0002132_abnormal_respiratory_system | 2.22609653 |
20 | MP0005220_abnormal_exocrine_pancreas | 2.10588516 |
21 | MP0002822_catalepsy | 2.10159585 |
22 | MP0005451_abnormal_body_composition | 2.06412819 |
23 | MP0004859_abnormal_synaptic_plasticity | 2.05905430 |
24 | MP0003436_decreased_susceptibility_to | 2.05720181 |
25 | MP0005085_abnormal_gallbladder_physiolo | 2.01269477 |
26 | MP0003329_amyloid_beta_deposits | 2.00626113 |
27 | MP0003183_abnormal_peptide_metabolism | 1.95657403 |
28 | MP0001944_abnormal_pancreas_morphology | 1.95442042 |
29 | MP0002877_abnormal_melanocyte_morpholog | 1.92544990 |
30 | MP0003300_gastrointestinal_ulcer | 1.92524570 |
31 | MP0003195_calcinosis | 1.88052018 |
32 | MP0002693_abnormal_pancreas_physiology | 1.79555491 |
33 | MP0008961_abnormal_basal_metabolism | 1.79149974 |
34 | MP0003868_abnormal_feces_composition | 1.75405831 |
35 | MP0003635_abnormal_synaptic_transmissio | 1.75162053 |
36 | MP0003122_maternal_imprinting | 1.74427124 |
37 | MP0004130_abnormal_muscle_cell | 1.70999021 |
38 | MP0002078_abnormal_glucose_homeostasis | 1.70853850 |
39 | MP0005083_abnormal_biliary_tract | 1.68233936 |
40 | MP0008004_abnormal_stomach_pH | 1.66338055 |
41 | MP0004270_analgesia | 1.62295086 |
42 | MP0002419_abnormal_innate_immunity | 1.57832523 |
43 | MP0000003_abnormal_adipose_tissue | 1.57430884 |
44 | MP0005075_abnormal_melanosome_morpholog | 1.56613207 |
45 | MP0003283_abnormal_digestive_organ | 1.54946718 |
46 | MP0005058_abnormal_lysosome_morphology | 1.54881094 |
47 | MP0002796_impaired_skin_barrier | 1.52858839 |
48 | MP0010329_abnormal_lipoprotein_level | 1.52772942 |
49 | MP0010678_abnormal_skin_adnexa | 1.47580246 |
50 | MP0005409_darkened_coat_color | 1.47157967 |
51 | MP0005025_abnormal_response_to | 1.46398890 |
52 | MP0001800_abnormal_humoral_immune | 1.46376116 |
53 | MP0005360_urolithiasis | 1.46200037 |
54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.44403970 |
55 | MP0001851_eye_inflammation | 1.43869402 |
56 | MP0004264_abnormal_extraembryonic_tissu | 1.43162189 |
57 | MP0001765_abnormal_ion_homeostasis | 1.42591918 |
58 | MP0000371_diluted_coat_color | 1.42363047 |
59 | MP0003303_peritoneal_inflammation | 1.41955535 |
60 | MP0002118_abnormal_lipid_homeostasis | 1.38473394 |
61 | MP0000015_abnormal_ear_pigmentation | 1.37784891 |
62 | MP0000427_abnormal_hair_cycle | 1.35987283 |
63 | MP0003045_fibrosis | 1.34374491 |
64 | MP0003252_abnormal_bile_duct | 1.33865667 |
65 | MP0000383_abnormal_hair_follicle | 1.33721792 |
66 | MP0005535_abnormal_body_temperature | 1.33631860 |
67 | MP0001756_abnormal_urination | 1.33625307 |
68 | MP0005387_immune_system_phenotype | 1.33181512 |
69 | MP0001790_abnormal_immune_system | 1.33181512 |
70 | MP0000372_irregular_coat_pigmentation | 1.31950965 |
71 | MP0004947_skin_inflammation | 1.31035811 |
72 | MP0002063_abnormal_learning/memory/cond | 1.29009275 |
73 | MP0006072_abnormal_retinal_apoptosis | 1.28980614 |
74 | MP0003172_abnormal_lysosome_physiology | 1.28013237 |
75 | MP0005332_abnormal_amino_acid | 1.24734587 |
76 | MP0009643_abnormal_urine_homeostasis | 1.24562665 |
77 | MP0001664_abnormal_digestion | 1.24551458 |
78 | MP0002733_abnormal_thermal_nociception | 1.24340412 |
79 | MP0001501_abnormal_sleep_pattern | 1.22357022 |
80 | MP0000685_abnormal_immune_system | 1.21620655 |
81 | MP0005248_abnormal_Harderian_gland | 1.21263840 |
82 | MP0005646_abnormal_pituitary_gland | 1.19605191 |
83 | MP0005670_abnormal_white_adipose | 1.19592798 |
84 | MP0002734_abnormal_mechanical_nocicepti | 1.19097474 |
85 | MP0002723_abnormal_immune_serum | 1.18494707 |
86 | MP0003953_abnormal_hormone_level | 1.17333906 |
87 | MP0002098_abnormal_vibrissa_morphology | 1.15259705 |
88 | MP0004036_abnormal_muscle_relaxation | 1.15251929 |
89 | MP0001970_abnormal_pain_threshold | 1.12676634 |
90 | MP0001819_abnormal_immune_cell | 1.11968487 |
91 | MP0000604_amyloidosis | 1.11898470 |
92 | MP0002420_abnormal_adaptive_immunity | 1.11527964 |
93 | MP0009785_altered_susceptibility_to | 1.11121532 |
94 | MP0003879_abnormal_hair_cell | 1.10865235 |
95 | MP0010155_abnormal_intestine_physiology | 1.10426180 |
96 | MP0002452_abnormal_antigen_presenting | 1.10251384 |
97 | MP0005187_abnormal_penis_morphology | 1.09877169 |
98 | MP0005408_hypopigmentation | 1.09762061 |
99 | MP0004484_altered_response_of | 1.09339492 |
100 | MP0000747_muscle_weakness | 1.08405119 |
101 | MP0005464_abnormal_platelet_physiology | 1.08144021 |
102 | MP0004084_abnormal_cardiac_muscle | 1.07785397 |
103 | MP0002064_seizures | 1.07288592 |
104 | MP0004885_abnormal_endolymph | 1.06722345 |
105 | MP0000751_myopathy | 1.06091637 |
106 | MP0001533_abnormal_skeleton_physiology | 1.06086514 |
107 | MP0003763_abnormal_thymus_physiology | 1.04806954 |
108 | MP0004215_abnormal_myocardial_fiber | 1.04360347 |
109 | MP0000465_gastrointestinal_hemorrhage | 1.02400173 |
110 | MP0005636_abnormal_mineral_homeostasis | 1.02166324 |
111 | MP0005375_adipose_tissue_phenotype | 1.01926999 |
112 | MP0005448_abnormal_energy_balance | 1.01779685 |
113 | MP0005671_abnormal_response_to | 1.01762848 |
114 | MP0008569_lethality_at_weaning | 1.01658398 |
115 | MP0003453_abnormal_keratinocyte_physiol | 1.01031970 |
116 | MP0002277_abnormal_respiratory_mucosa | 0.99830314 |
117 | MP0002090_abnormal_vision | 0.99805291 |
118 | MP0002876_abnormal_thyroid_physiology | 0.99627388 |
119 | MP0005386_behavior/neurological_phenoty | 0.97227036 |
120 | MP0004924_abnormal_behavior | 0.97227036 |
121 | MP0002557_abnormal_social/conspecific_i | 0.96915147 |
122 | MP0002234_abnormal_pharynx_morphology | 0.95807619 |
123 | MP0009745_abnormal_behavioral_response | 0.95661111 |
124 | MP0005000_abnormal_immune_tolerance | 0.95467758 |
125 | MP0003123_paternal_imprinting | 0.95267320 |
126 | MP0002928_abnormal_bile_duct | 0.93656236 |
127 | MP0004085_abnormal_heartbeat | 0.92249054 |
128 | MP0003633_abnormal_nervous_system | 0.92238802 |
129 | MP0001845_abnormal_inflammatory_respons | 0.92069176 |
130 | MP0001502_abnormal_circadian_rhythm | 0.91938214 |
131 | MP0009046_muscle_twitch | 0.91483946 |
132 | MP0002272_abnormal_nervous_system | 0.91163481 |
133 | MP0001984_abnormal_olfaction | 0.90906865 |
134 | MP0004883_abnormal_blood_vessel | 0.90416014 |
135 | MP0003690_abnormal_glial_cell | 0.89768577 |
136 | MP0000462_abnormal_digestive_system | 0.89133158 |
137 | MP0002896_abnormal_bone_mineralization | 0.89062208 |
138 | MP0003959_abnormal_lean_body | 0.88984661 |
139 | MP0000230_abnormal_systemic_arterial | 0.88767721 |
140 | MP0003656_abnormal_erythrocyte_physiolo | 0.87369623 |
141 | MP0002971_abnormal_brown_adipose | 0.87026611 |
142 | MP0003646_muscle_fatigue | 0.86423355 |
143 | MP0002269_muscular_atrophy | 0.85336847 |
144 | MP0005310_abnormal_salivary_gland | 0.84157535 |
145 | MP0005319_abnormal_enzyme/_coenzyme | 0.82589036 |
146 | MP0002572_abnormal_emotion/affect_behav | 0.82226899 |
147 | MP0004858_abnormal_nervous_system | 0.81972525 |
148 | MP0003137_abnormal_impulse_conducting | 0.81805369 |
149 | MP0006276_abnormal_autonomic_nervous | 0.81536992 |
150 | MP0000609_abnormal_liver_physiology | 0.81389692 |
151 | MP0002069_abnormal_eating/drinking_beha | 0.81037943 |
152 | MP0006082_CNS_inflammation | 0.80440874 |
153 | MP0000470_abnormal_stomach_morphology | 0.80248547 |
154 | MP0003705_abnormal_hypodermis_morpholog | 0.79659427 |
155 | MP0000377_abnormal_hair_follicle | 0.79257787 |
156 | MP0005666_abnormal_adipose_tissue | 0.79138042 |
157 | MP0001485_abnormal_pinna_reflex | 0.78333083 |
158 | MP0005334_abnormal_fat_pad | 0.77667303 |
159 | MP0003866_abnormal_defecation | 0.77007887 |
160 | MP0000367_abnormal_coat/_hair | 0.76814130 |
161 | MP0000716_abnormal_immune_system | 0.76338278 |
162 | MP0002405_respiratory_system_inflammati | 0.76147616 |
163 | MP0003638_abnormal_response/metabolism_ | 0.75987934 |
164 | MP0004811_abnormal_neuron_physiology | 0.75180084 |
165 | MP0001835_abnormal_antigen_presentation | 0.75166769 |
166 | MP0004019_abnormal_vitamin_homeostasis | 0.73895723 |
167 | MP0009115_abnormal_fat_cell | 0.73390785 |
168 | MP0001486_abnormal_startle_reflex | 0.70285701 |
169 | MP0008872_abnormal_physiological_respon | 0.69193301 |
170 | MP0001545_abnormal_hematopoietic_system | 0.69001302 |
171 | MP0005397_hematopoietic_system_phenotyp | 0.69001302 |
172 | MP0008874_decreased_physiological_sensi | 0.67824992 |
173 | MP0000920_abnormal_myelination | 0.67356967 |
174 | MP0002148_abnormal_hypersensitivity_rea | 0.67009786 |
175 | MP0003828_pulmonary_edema | 0.66365488 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.19525020 |
2 | Ketoacidosis (HP:0001993) | 3.96309559 |
3 | Hypoglycemic coma (HP:0001325) | 3.94928181 |
4 | Recurrent bacterial skin infections (HP:0005406) | 3.78474193 |
5 | Recurrent abscess formation (HP:0002722) | 3.62183099 |
6 | Abnormality of macrophages (HP:0004311) | 3.61130297 |
7 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.56710140 |
8 | Orchitis (HP:0100796) | 3.54282324 |
9 | Visual hallucinations (HP:0002367) | 3.52150637 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.50364863 |
11 | Increased IgE level (HP:0003212) | 3.41622864 |
12 | Gastrointestinal infarctions (HP:0005244) | 3.41230453 |
13 | Optic neuritis (HP:0100653) | 3.34812354 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.34812354 |
15 | Gout (HP:0001997) | 3.34457724 |
16 | Generalized aminoaciduria (HP:0002909) | 3.32656261 |
17 | Myositis (HP:0100614) | 3.31016531 |
18 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.29761135 |
19 | Ketosis (HP:0001946) | 3.26356703 |
20 | Hyperglycemia (HP:0003074) | 3.18635354 |
21 | Hypoglycemic seizures (HP:0002173) | 3.10728886 |
22 | Agitation (HP:0000713) | 3.09450443 |
23 | Hypochromic microcytic anemia (HP:0004840) | 3.07999051 |
24 | Gingivitis (HP:0000230) | 2.94210106 |
25 | Pheochromocytoma (HP:0002666) | 2.93213287 |
26 | Keratoconjunctivitis sicca (HP:0001097) | 2.89063610 |
27 | Subacute progressive viral hepatitis (HP:0006572) | 2.83352511 |
28 | Symptomatic seizures (HP:0011145) | 2.78717773 |
29 | Ocular albinism (HP:0001107) | 2.74064098 |
30 | Hypochromic anemia (HP:0001931) | 2.69527351 |
31 | Keratoconjunctivitis (HP:0001096) | 2.68644077 |
32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.68533773 |
33 | Hypothermia (HP:0002045) | 2.64412938 |
34 | Dysostosis multiplex (HP:0000943) | 2.63244525 |
35 | Curly hair (HP:0002212) | 2.61050951 |
36 | Stomatitis (HP:0010280) | 2.60801316 |
37 | Late onset (HP:0003584) | 2.60445439 |
38 | Gingival bleeding (HP:0000225) | 2.60173086 |
39 | Ventricular fibrillation (HP:0001663) | 2.55914634 |
40 | Myoglobinuria (HP:0002913) | 2.55899406 |
41 | Prolonged bleeding time (HP:0003010) | 2.55334599 |
42 | Micronodular cirrhosis (HP:0001413) | 2.52839698 |
43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52241114 |
44 | Mucopolysacchariduria (HP:0008155) | 2.52241114 |
45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.50528564 |
46 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.49571558 |
47 | Neuroendocrine neoplasm (HP:0100634) | 2.42975724 |
48 | Oligomenorrhea (HP:0000876) | 2.42577984 |
49 | Iris hypopigmentation (HP:0007730) | 2.42363102 |
50 | Hyperactive renin-angiotensin system (HP:0000841) | 2.42343417 |
51 | Right ventricular cardiomyopathy (HP:0011663) | 2.41973168 |
52 | Abnormality of nail color (HP:0100643) | 2.39004645 |
53 | Lip pit (HP:0100267) | 2.37784713 |
54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.34380152 |
55 | Palpitations (HP:0001962) | 2.32470582 |
56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32354565 |
57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32354565 |
58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32354565 |
59 | Bundle branch block (HP:0011710) | 2.30355230 |
60 | Growth hormone excess (HP:0000845) | 2.26205291 |
61 | Pustule (HP:0200039) | 2.25065680 |
62 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.24789925 |
63 | Urticaria (HP:0001025) | 2.24476735 |
64 | Recurrent skin infections (HP:0001581) | 2.22555721 |
65 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.21901371 |
66 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.21901371 |
67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.20343522 |
68 | Syncope (HP:0001279) | 2.20112198 |
69 | Decreased circulating renin level (HP:0003351) | 2.20093546 |
70 | Central scotoma (HP:0000603) | 2.18395908 |
71 | Mediastinal lymphadenopathy (HP:0100721) | 2.18013374 |
72 | Hypsarrhythmia (HP:0002521) | 2.16829798 |
73 | Peritonitis (HP:0002586) | 2.14195062 |
74 | Abnormality of purine metabolism (HP:0004352) | 2.13730390 |
75 | Long toe (HP:0010511) | 2.13613897 |
76 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13606920 |
77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.13564394 |
78 | Anxiety (HP:0000739) | 2.13455820 |
79 | Amyloidosis (HP:0011034) | 2.13137601 |
80 | Episodic fever (HP:0001954) | 2.12619992 |
81 | Obstructive lung disease (HP:0006536) | 2.09948982 |
82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.09948982 |
83 | Epileptiform EEG discharges (HP:0011182) | 2.07848223 |
84 | Concave nail (HP:0001598) | 2.04092453 |
85 | Recurrent fungal infections (HP:0002841) | 2.02279695 |
86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01600335 |
87 | Hypoplasia of the fovea (HP:0007750) | 1.99603063 |
88 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.99603063 |
89 | Palmoplantar hyperkeratosis (HP:0000972) | 1.99131009 |
90 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.99123870 |
91 | Papilledema (HP:0001085) | 1.98973498 |
92 | Chest pain (HP:0100749) | 1.98149369 |
93 | Thick nail (HP:0001805) | 1.97835165 |
94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97675000 |
95 | Depression (HP:0000716) | 1.97404464 |
96 | Hyperglycinuria (HP:0003108) | 1.95729398 |
97 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.95289401 |
98 | Hyperkalemia (HP:0002153) | 1.94973145 |
99 | Prolonged QT interval (HP:0001657) | 1.94291336 |
100 | Insulin resistance (HP:0000855) | 1.92418955 |
101 | Sudden death (HP:0001699) | 1.92177486 |
102 | Increased cerebral lipofuscin (HP:0011813) | 1.92111523 |
103 | Myokymia (HP:0002411) | 1.90733044 |
104 | Hypokalemia (HP:0002900) | 1.90518222 |
105 | Ankle clonus (HP:0011448) | 1.89840440 |
106 | Resting tremor (HP:0002322) | 1.88772570 |
107 | Macroorchidism (HP:0000053) | 1.88389958 |
108 | Focal seizures (HP:0007359) | 1.87612924 |
109 | Xanthomatosis (HP:0000991) | 1.87078265 |
110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87060656 |
111 | Abnormal social behavior (HP:0012433) | 1.85986209 |
112 | Impaired social interactions (HP:0000735) | 1.85986209 |
113 | Vasculitis (HP:0002633) | 1.85261367 |
114 | Abnormality of pain sensation (HP:0010832) | 1.85113258 |
115 | Impaired pain sensation (HP:0007328) | 1.85113258 |
116 | Conjunctival hamartoma (HP:0100780) | 1.84979022 |
117 | Hyperparathyroidism (HP:0000843) | 1.84977703 |
118 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84971602 |
119 | Gangrene (HP:0100758) | 1.84703683 |
120 | Abnormality of renin-angiotensin system (HP:0000847) | 1.84578291 |
121 | Inflammation of the large intestine (HP:0002037) | 1.84059825 |
122 | Hypercortisolism (HP:0001578) | 1.83429335 |
123 | Global brain atrophy (HP:0002283) | 1.82651669 |
124 | Abnormality of chloride homeostasis (HP:0011422) | 1.82567692 |
125 | Chronic diarrhea (HP:0002028) | 1.82179097 |
126 | Supranuclear gaze palsy (HP:0000605) | 1.81084027 |
127 | Arterial thrombosis (HP:0004420) | 1.80642576 |
128 | Restlessness (HP:0000711) | 1.80359461 |
129 | Plantar hyperkeratosis (HP:0007556) | 1.80228552 |
130 | Protuberant abdomen (HP:0001538) | 1.79542191 |
131 | Encephalitis (HP:0002383) | 1.79445682 |
132 | Hyperuricemia (HP:0002149) | 1.79117866 |
133 | Increased purine levels (HP:0004368) | 1.79117866 |
134 | Generalized hypopigmentation (HP:0007513) | 1.78373282 |
135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77140475 |
136 | Meningitis (HP:0001287) | 1.76996951 |
137 | Abnormality of potassium homeostasis (HP:0011042) | 1.76960507 |
138 | Sepsis (HP:0100806) | 1.76946774 |
139 | Hamartoma of the eye (HP:0010568) | 1.74357332 |
140 | Severe short stature (HP:0003510) | 1.74267339 |
141 | Torticollis (HP:0000473) | 1.74234423 |
142 | Onion bulb formation (HP:0003383) | 1.73638021 |
143 | Decreased motor nerve conduction velocity (HP:0003431) | 1.72419473 |
144 | Craniofacial dystonia (HP:0012179) | 1.72326699 |
145 | Gastrointestinal inflammation (HP:0004386) | 1.72301100 |
146 | Hyperglycinemia (HP:0002154) | 1.71921377 |
147 | Abdominal distention (HP:0003270) | 1.71694172 |
148 | Deep venous thrombosis (HP:0002625) | 1.71299352 |
149 | Action tremor (HP:0002345) | 1.71111717 |
150 | Abnormality of iron homeostasis (HP:0011031) | 1.70681678 |
151 | Interstitial pulmonary disease (HP:0006530) | 1.70514491 |
152 | Postural tremor (HP:0002174) | 1.70148131 |
153 | Palmar hyperkeratosis (HP:0010765) | 1.69610798 |
154 | Papillary thyroid carcinoma (HP:0002895) | 1.69560235 |
155 | Sensorimotor neuropathy (HP:0007141) | 1.68365195 |
156 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68296965 |
157 | Abnormality of the common coagulation pathway (HP:0010990) | 1.67769948 |
158 | Generalized hypopigmentation of hair (HP:0011358) | 1.67347001 |
159 | Amelogenesis imperfecta (HP:0000705) | 1.67322863 |
160 | Generalized tonic-clonic seizures (HP:0002069) | 1.67274280 |
161 | Osteomyelitis (HP:0002754) | 1.66360013 |
162 | Testicular neoplasm (HP:0010788) | 1.65936502 |
163 | Spontaneous hematomas (HP:0007420) | 1.65838994 |
164 | Exercise-induced myalgia (HP:0003738) | 1.65717066 |
165 | Epistaxis (HP:0000421) | 1.65509780 |
166 | Asymmetric septal hypertrophy (HP:0001670) | 1.65468230 |
167 | Anorexia (HP:0002039) | 1.64902322 |
168 | Atrioventricular block (HP:0001678) | 1.64354045 |
169 | Focal dystonia (HP:0004373) | 1.63453853 |
170 | Drooling (HP:0002307) | 1.63404716 |
171 | Excessive salivation (HP:0003781) | 1.63404716 |
172 | Adrenal overactivity (HP:0002717) | 1.63366772 |
173 | Focal motor seizures (HP:0011153) | 1.62883102 |
174 | Hypotension (HP:0002615) | 1.61860474 |
175 | Cone-rod dystrophy (HP:0000548) | 1.61721244 |
176 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.61716204 |
177 | Retinal atrophy (HP:0001105) | 1.61562337 |
178 | Increased CSF protein (HP:0002922) | 1.60503546 |
179 | Cellulitis (HP:0100658) | 1.60468133 |
180 | Malnutrition (HP:0004395) | 1.59766762 |
181 | Postural instability (HP:0002172) | 1.58818231 |
182 | Hemoptysis (HP:0002105) | 1.58744984 |
183 | Viral hepatitis (HP:0006562) | 1.57691820 |
184 | Widely spaced teeth (HP:0000687) | 1.57271431 |
185 | Cheilitis (HP:0100825) | 1.56347183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 3.66271239 |
2 | TRIB3 | 3.32560913 |
3 | MAP3K2 | 3.19985419 |
4 | RIPK4 | 2.98384604 |
5 | BCKDK | 2.59703594 |
6 | ERN1 | 2.54373589 |
7 | INSRR | 2.54279920 |
8 | IRAK4 | 2.29616888 |
9 | KSR2 | 2.22306969 |
10 | EPHA2 | 2.20952162 |
11 | PKN2 | 2.19701519 |
12 | MAP3K9 | 2.12397172 |
13 | GRK6 | 2.09263145 |
14 | FRK | 2.00750558 |
15 | MAP3K12 | 1.96996491 |
16 | TNK2 | 1.93003767 |
17 | MARK1 | 1.85943086 |
18 | PAK3 | 1.75211978 |
19 | TAOK3 | 1.72957123 |
20 | PHKG2 | 1.72821335 |
21 | PHKG1 | 1.72821335 |
22 | MAP3K4 | 1.72640831 |
23 | NTRK3 | 1.64782047 |
24 | MINK1 | 1.64727953 |
25 | BLK | 1.61021713 |
26 | SCYL2 | 1.57342866 |
27 | NTRK1 | 1.53992735 |
28 | PRKD3 | 1.50770122 |
29 | MYLK | 1.50556422 |
30 | CSK | 1.49338766 |
31 | RET | 1.48415620 |
32 | RIPK1 | 1.48102108 |
33 | MAP2K2 | 1.46421845 |
34 | MST1R | 1.46036767 |
35 | SIK1 | 1.40046709 |
36 | AKT3 | 1.36917297 |
37 | CAMKK1 | 1.36167588 |
38 | MAP4K1 | 1.34503788 |
39 | TYK2 | 1.32386853 |
40 | TAOK1 | 1.32160611 |
41 | MAP2K4 | 1.31989545 |
42 | IRAK1 | 1.28219680 |
43 | HIPK2 | 1.22914909 |
44 | ZAP70 | 1.22325612 |
45 | MAP3K1 | 1.18855533 |
46 | FGFR3 | 1.18530684 |
47 | RPS6KA2 | 1.17588244 |
48 | FGR | 1.17037211 |
49 | CAMKK2 | 1.15715942 |
50 | CDK12 | 1.14960143 |
51 | TESK1 | 1.14917040 |
52 | MAP2K6 | 1.14532222 |
53 | DAPK2 | 1.13743578 |
54 | PIK3CA | 1.12949924 |
55 | PTK2 | 1.12458419 |
56 | FES | 1.10295022 |
57 | PRKCH | 1.09513904 |
58 | FER | 1.09460680 |
59 | JAK3 | 1.08597108 |
60 | PTK6 | 1.06732411 |
61 | NEK6 | 1.06531272 |
62 | YES1 | 1.05681426 |
63 | MAP2K1 | 1.03646099 |
64 | PDK3 | 1.03231050 |
65 | PDK4 | 1.03231050 |
66 | PRKD2 | 1.01502620 |
67 | WNK4 | 1.00735728 |
68 | CASK | 0.98768796 |
69 | PRKAA2 | 0.97237227 |
70 | MAP3K13 | 0.95373876 |
71 | TTN | 0.95099349 |
72 | HCK | 0.93296838 |
73 | PDGFRA | 0.93075813 |
74 | SIK3 | 0.92335592 |
75 | BTK | 0.91224732 |
76 | PTK2B | 0.88791988 |
77 | CAMK2D | 0.87175358 |
78 | ICK | 0.85545761 |
79 | TESK2 | 0.84976383 |
80 | SYK | 0.84836038 |
81 | IRAK2 | 0.84685675 |
82 | NEK1 | 0.84100098 |
83 | PAK6 | 0.82860763 |
84 | IKBKE | 0.82481036 |
85 | MARK3 | 0.81043914 |
86 | EEF2K | 0.79944007 |
87 | PRKAA1 | 0.79423354 |
88 | STK11 | 0.77930839 |
89 | PDPK1 | 0.76099803 |
90 | PINK1 | 0.75064067 |
91 | LIMK1 | 0.73290548 |
92 | MAP2K3 | 0.72697191 |
93 | KSR1 | 0.71458010 |
94 | MARK2 | 0.71401934 |
95 | STK38 | 0.69552179 |
96 | MAP3K3 | 0.69336834 |
97 | MAP3K6 | 0.67495335 |
98 | MAPKAPK3 | 0.67166551 |
99 | PRKG2 | 0.66750802 |
100 | LRRK2 | 0.66547753 |
101 | CDK5 | 0.66085913 |
102 | SGK3 | 0.64547121 |
103 | FGFR4 | 0.62948112 |
104 | SMG1 | 0.62272760 |
105 | ERBB2 | 0.62241658 |
106 | NTRK2 | 0.62127185 |
107 | MAP3K7 | 0.61615853 |
108 | LYN | 0.60173631 |
109 | PDK1 | 0.58770277 |
110 | MAPK15 | 0.58435306 |
111 | OXSR1 | 0.57352259 |
112 | MAP2K7 | 0.57349657 |
113 | MAP3K11 | 0.57195549 |
114 | CDC42BPA | 0.55544542 |
115 | TYRO3 | 0.55341180 |
116 | MAP3K5 | 0.54806993 |
117 | SGK223 | 0.53203428 |
118 | SGK494 | 0.53203428 |
119 | DAPK1 | 0.51866754 |
120 | CSNK1G2 | 0.51618954 |
121 | LCK | 0.51058768 |
122 | IKBKB | 0.50869522 |
123 | FYN | 0.50736951 |
124 | ACVR1B | 0.50472064 |
125 | CHUK | 0.49740200 |
126 | NLK | 0.49394142 |
127 | DYRK1B | 0.48499088 |
128 | DYRK1A | 0.47826652 |
129 | SIK2 | 0.47647071 |
130 | JAK2 | 0.46219861 |
131 | WNK1 | 0.45086517 |
132 | ILK | 0.44833721 |
133 | PRKCZ | 0.44008767 |
134 | DMPK | 0.42750410 |
135 | EPHA3 | 0.41301770 |
136 | PASK | 0.39939691 |
137 | PRKD1 | 0.39351563 |
138 | CAMK1 | 0.38980125 |
139 | WNK3 | 0.38653435 |
140 | SGK2 | 0.38254122 |
141 | JAK1 | 0.37782952 |
142 | PRKCG | 0.37755499 |
143 | EPHB1 | 0.37735119 |
144 | PRKCE | 0.37617024 |
145 | PDK2 | 0.37352879 |
146 | FLT3 | 0.32899986 |
147 | PRKACG | 0.32656536 |
148 | ERBB3 | 0.32073206 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.43494021 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.69583514 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.53687628 |
4 | Insulin secretion_Homo sapiens_hsa04911 | 1.93253789 |
5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92942028 |
6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.74776348 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70575444 |
8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68747506 |
9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66782195 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.65112103 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63812500 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63308997 |
13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56920368 |
14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52602276 |
15 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.50394946 |
16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49560535 |
17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48136687 |
18 | Protein export_Homo sapiens_hsa03060 | 1.48060994 |
19 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.47895790 |
20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45428002 |
21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45169143 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43312858 |
23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41548070 |
24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37280004 |
25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34497073 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32612930 |
27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31108530 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.29309752 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28866366 |
30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.28520800 |
31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.28408158 |
32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26495390 |
33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25207670 |
34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.25192280 |
35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23538842 |
36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23450889 |
37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.22503627 |
38 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.21804486 |
39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21688139 |
40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19421277 |
41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.18589868 |
42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15335468 |
43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12893865 |
44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10892660 |
45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09199470 |
46 | Bile secretion_Homo sapiens_hsa04976 | 1.07627953 |
47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07201208 |
48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07125901 |
49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05928348 |
50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.05761167 |
51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05604209 |
52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05272609 |
53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.05086054 |
54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04933845 |
55 | Platelet activation_Homo sapiens_hsa04611 | 1.04380408 |
56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04142154 |
57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03958435 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02054307 |
59 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00003589 |
60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99608256 |
61 | Insulin resistance_Homo sapiens_hsa04931 | 0.99495544 |
62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99191731 |
63 | Hepatitis C_Homo sapiens_hsa05160 | 0.99034673 |
64 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98465997 |
65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97689087 |
66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97361548 |
67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97048714 |
68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95815194 |
69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95703235 |
70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94493911 |
71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.94391037 |
72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94364331 |
73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94340196 |
74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92513425 |
75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92503154 |
76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88717355 |
77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87899441 |
78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87288362 |
79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87211933 |
80 | Salivary secretion_Homo sapiens_hsa04970 | 0.86924749 |
81 | Morphine addiction_Homo sapiens_hsa05032 | 0.86887746 |
82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86844457 |
83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86082083 |
84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86032058 |
85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85031668 |
86 | Long-term depression_Homo sapiens_hsa04730 | 0.84076629 |
87 | Taste transduction_Homo sapiens_hsa04742 | 0.84055187 |
88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83409974 |
89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83112420 |
90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83003624 |
91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82530254 |
92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82455447 |
93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82298513 |
94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81604536 |
95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80932495 |
96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80583537 |
97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80078769 |
98 | Lysosome_Homo sapiens_hsa04142 | 0.79781511 |
99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78664120 |
100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78314736 |
101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77998068 |
102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77657335 |
103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77183057 |
104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76038964 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75614589 |
106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75503627 |
107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75327028 |
108 | Renin secretion_Homo sapiens_hsa04924 | 0.74277588 |
109 | Measles_Homo sapiens_hsa05162 | 0.73602367 |
110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71954187 |
111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71562969 |
112 | ABC transporters_Homo sapiens_hsa02010 | 0.70418746 |
113 | Phagosome_Homo sapiens_hsa04145 | 0.69758573 |
114 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69734032 |
115 | Influenza A_Homo sapiens_hsa05164 | 0.69440688 |
116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69238594 |
117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68072607 |
118 | Legionellosis_Homo sapiens_hsa05134 | 0.67494396 |
119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67070290 |
120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66865245 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65744134 |
122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65115044 |
123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64959209 |
124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63673048 |
125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63228687 |
126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61918930 |
127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61783395 |
128 | Glioma_Homo sapiens_hsa05214 | 0.60495457 |
129 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59522732 |
130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59416508 |
131 | Malaria_Homo sapiens_hsa05144 | 0.59040701 |
132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57748144 |
133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57537988 |
134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57119763 |
135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56847974 |
136 | Hepatitis B_Homo sapiens_hsa05161 | 0.56205743 |
137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56049292 |
138 | Mineral absorption_Homo sapiens_hsa04978 | 0.56037491 |
139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55606002 |
140 | Nicotine addiction_Homo sapiens_hsa05033 | 0.54918872 |
141 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53722951 |
142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53699852 |
143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52926121 |
144 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52811344 |
145 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51859195 |
146 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51424430 |
147 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50953059 |
148 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49635059 |
149 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49482709 |
150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48624372 |
151 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48546122 |
152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48018795 |
153 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47804109 |
154 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47341910 |
155 | Gap junction_Homo sapiens_hsa04540 | 0.46974795 |
156 | Peroxisome_Homo sapiens_hsa04146 | 0.46658322 |
157 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46086331 |
158 | Endocytosis_Homo sapiens_hsa04144 | 0.44155063 |
159 | Prion diseases_Homo sapiens_hsa05020 | 0.41069808 |
160 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39091549 |
161 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38711501 |